Allergy Research Group, L-Ornithine-L-Aspartate, 100 grams (3.5 oz)
UPC Code: 713947761001
Description
L-Ornithine-L-Aspartate (LOLA) supports healthy nitrogen metabolism by promoting the natural detoxification of ammonia through the urea cycle and glutamine synthesis pathways. This clinically relevant formula helps maintain liver function, ammonia clearance, and overall metabolic balance, particularly during periods of increased nitrogen stress.
Packaging
100 grams (3.5 oz)
Suggested Use
As a dietary supplement, take 1 rounded teaspoon three times daily, or as directed by a healthcare practitioner.
About Allergy Research Group
For more than 45 years, Allergy Research Group has supported healthcare providers and their patients with the tools necessary to achieve the confidence that comes from great health. Our tireless dedication to creating clinically sound, evidence-based, condition-specific formulas using clean, hypoallergenic ingredients is unsurpassed—and it’s why our supplements are so widely trusted and well-tolerated by both practitioners and patients worldwide.
By offering innovative solutions backed by science, we empower healthcare practitioners to improve the health and confidence of every patient they serve.
Our supplements transcend trends because we move with the science. And while fads may come and go, we’ve consistently stayed one step ahead of the VMS industry. We were first to introduce the US market to effective supplements like melatonin, 5-HTP, Artemisinin, Nattokinase and many others—and this commitment to innovation continues today.
Safety
Please consult your health care provider if currently under care or treatment or for pregnancy, nursing, and child safety instructions. Keep out of reach of children. Do not exceed recommended serving. See product packaging for additional safety information.
Disclaimer
Individual results may vary. This product is not intended to diagnose, treat, cure or prevent any disease. The statements on this website and all affiliates have not been evaluated by the FDA. Advice on treatment or care of an individual patient should be obtained through consultation with a trained health care practitioner.